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The mammalian pineal organ is a peripheral oscillator,
depending on afferent information from the so-called
master clock in the suprachiasmatic nuclei of the hypoth-
alamus. One of the best studied outputs of the pineal
gland is the small and hydrophobic molecule melatonin.
In all vertebrates, melatonin is synthesized rhythmically
with high levels at night, signalling the body the duration
of the dark period. Changes or disruptions of melatonin
rhythms in humans are related to a number of pathophys-
iological disorders, like Alzheimer's disease, seasonal
affective disorder or the Smith-Magenis-Syndrome. To use
melatonin in preventive or curative interferences with the
human circadian system, a complete understanding of the
generation of the rhythmic melatonin signal in the
human pineal gland is essential.
Melatonin biosynthesis is best studied in the rodent pin-
eal gland, where the activity of the penultimate and rate-
limiting enzyme, the arylalkylamine N-acetyltransferase
(AA-NAT), is regulated on the transcriptional level,
whereas the regulatory role of the ultimate enzymatic
step, achieved by the hydroxyindole O-methyltransferase
(HIOMT), is still under debate. In rodents, Aa-nat mRNA
is about 100-fold elevated during the night in response to
adrenergic stimulation of the cAMP-signalling pathway,
with AA-NAT protein levels closely following this dynam-
ics. In contrast, in all ungulates studied so far (cow,
sheep), a post-transcriptional regulation of the AA-NAT is
central to determine rhythmic melatonin synthesis. AA-
NAT mRNA levels are constantly elevated, and lead to a
constitutive up-regulation of AA-NAT protein, which is,
however, rapidly degraded via proteasomal proteolysis
during the day. AA-NAT proteolysis is only terminated
upon the nocturnal increase in cAMP levels.
Similar to ungulates, a post-transcriptional control of this
enzyme seems evident in the pineal gland of the primate
Macaca mulatta.
Studies on the molecular basis of melatonin synthesis in
the human being are sparse and almost exclusively based
on phenomenological data, derived from non-invasive
investigations. Yet the molecular mechanisms underlying
the generation of the hormonal message of darkness can
currently only be deciphered using autoptic material. We
therefore analyzed in human post-mortem pineal tissue
Aa-nat and Hiomt mRNA levels, AA-NAT and HIOMT
enzyme activity, and melatonin levels for the first time
simultaneously within tissue samples of the same speci-
men. Here presented data show the feasibility of this
approach. Our results depict a clear diurnal rhythm in AA-
NAT activity and melatonin content, despite constant val-
ues for Aa-nat and Hiomt mRNA, and for HIOMT activity.
Notably, the here elevated AA-NAT activity during the
dusk period does not correspond to a simultaneous eleva-
tion in melatonin content. It is currently unclear whether
this finding may suggest a more important role of the ulti-
mate enzyme in melatonin synthesis, the HIOMT, for
rate-limiting the melatonin rhythm, as reported recently
for the rodent pineal gland.
Thus, our data support for the first time experimentally
that post-transcriptional mechanisms are responsible for
the generation of rhythmic melatonin synthesis in the
human pineal gland.
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